未登录

I

Ignacio Atal

assistance publique hopitaux paris (aphp)

H指数:13

被引数:877

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

External factors may influence Cochrane reviewers when classifying the risk of bias of original reports

JOURNAL OF CLINICAL EPIDEMIOLOGY

IF5.2

2020-07-011

OAAI

Randomized clinical trials in ANCA-associated vasculitis: a systematic analysis of the WHO-International Clinical Trials Registry Platform

ORPHANET JOURNAL OF RARE DISEASES

IF3.5

2020-05-292

OAAI

Ten Years of Interventional Research in Systemic Sclerosis: A Systematic Mapping of Trial Registries

ARTHRITIS CARE & RESEARCH

IF3.3

2019-12-104

PREAI

The statistical significance of meta-analyses is frequently fragile: definition of a fragility index for meta-analyses

JOURNAL OF CLINICAL EPIDEMIOLOGY

IF5.2

2019-07-0179

OAAI

Automatic screening using word embeddings achieved high sensitivity and workload reduction for updating living network meta-analyses

JOURNAL OF CLINICAL EPIDEMIOLOGY

IF5.2

2019-04-0117

OAAI

Association Between Publication Characteristics and Treatment Effect Estimates A Meta-epidemiologic Study

ANNALS OF INTERNAL MEDICINE

IF15.2

2018-09-1829

PREAI

Avoidable waste of research related to outcome planning and reporting in clinical trials

临床试验中与结果计划和报告相关的研究可避免的浪费

IF8.3

2018-06-1139

OAAI

A mapping of 115,000 randomized trials revealed a mismatch between research effort and health needs in non high-income regions

对115,000项随机试验的映射显示，非高收入地区的研究工作与健康需求之间存在不匹配

JOURNAL OF CLINICAL EPIDEMIOLOGY

IF5.2

2018-06-0127

PREAI

Factors Associated With Postmarketing Research for Approved Indications for Novel Medicines Approved by Both the FDA and EMA Between 2005 and 2010: A Multivariable Analysis

2005至2010间FDA和EMA批准的新药上市后研究的相关因素: 多变量分析

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2018-02-244

PREAI

Post-marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross-sectional study

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2017-10-1213

OAAI

Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study

Cochrane评价中包含的20项920随机对照试验随时间推移的不良报告和方法不足的演变: 研究性研究

BMJ-BRITISH MEDICAL JOURNAL

IF42.7

2017-06-08109

OAAI

Reporting of statistically significant results at ClinicalTrials.gov for completed superiority randomized controlled trials

IF8.3

2016-11-303

OAAI

Association between trial registration and treatment effect estimates: a meta-epidemiological study

IF8.3

2016-07-0445

OAAI